PremiumThe FlyDBV Technologies files to sell 289.01M ordinary shares for holders DBV Technologies price target raised to $16 from $7 at H.C. Wainwright DBV Technologies price target raised to $15 from $10 at Citizens JMP PremiumThe FlyBiotech Alert: Searches spiking for these stocks today DBV sinks after disclosing ‘substantial doubt’ of going concern Promising Outlook for DBV Technologies SA: Accelerated BLA Submission and Revenue Growth Potential PremiumThe FlyDBV Technologies announces three-year results from EPITOPE trial DBV Technologies Amends Executive Severance Agreements DBV Technologies Aligns with FDA for Viaskin Peanut Approval 
